Enzymology
Structural Basis for the Recognition of Peptide RJPXD33 by Acyltransferases in Lipid A Biosynthesis*

https://doi.org/10.1074/jbc.M114.564278Get rights and content
Under a Creative Commons license
open access

UDP-N-acetylglucosamine acyltransferase (LpxA) and UDP-3-O-(acyl)-glucosamine acyltransferase (LpxD) constitute the essential, early acyltransferases of lipid A biosynthesis. Recently, an antimicrobial peptide inhibitor, RJPXD33, was identified with dual affinity for LpxA and LpxD. To gain a fundamental understanding of the molecular basis of inhibitor binding, we determined the crystal structure of LpxA from Escherichia coli in complex with RJPXD33 at 1.9 Å resolutions. Our results suggest that the peptide binds in a unique modality that mimics (R)-β-hydroxyacyl pantetheine binding to LpxA and displays how the peptide binds exclusive of the native substrate, acyl-acyl carrier protein. Acyltransferase binding studies with photo-labile RJPXD33 probes and truncations of RJPXD33 validated the structure and provided fundamental insights for future design of small molecule inhibitors. Overlay of the LpxA-RJPXD33 structure with E. coli LpxD identified a complementary peptide binding pocket within LpxD and serves as a model for further biochemical characterization of RJPXD33 binding to LpxD.

Acyl Carrier Protein (ACP)
Antimicrobial Peptide (AMP)
Enzyme Inhibitor
Lipopolysaccharide (LPS)
Peptides
X-ray Crystallography
Acyltransferase
Lipid A
LpxA

Cited by (0)

*

This work was supported, in whole or in part, by National Institutes of Health Grant 5T32GM008597-14 (University of Michigan Chemistry-Biology Interface training program; to R. J. J.). This work was also supported in part by a Valteich Research Award administered by the College of Pharmacy, University of Michigan and by a Pre-doctoral Research Grant administered by the University of Michigan Rackham Graduate School.

The atomic coordinates and structure factors (code 8J09) have been deposited in the Protein Data Bank (http://wwpdb.org/).

1

Supported in part by and an American Foundation for Pharmaceutical Education fellowship.